ISSN: 1389-4501

Journal Home

Journal Guideline

Current Drug Targets Q2 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Drug Targets is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 119. It has a price of 1800 €. It has an SJR impact factor of 0,691 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,691.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Clinical Biochemistry (Q2) Drug Discovery (Q2) Pharmacology (Q2) Molecular Medicine (Q3)

Price

1800 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,691

SJR Impact factor

119

H Index

97

Total Docs (Last Year)

390

Total Docs (3 years)

10001

Total Refs

1214

Total Cites (3 years)

368

Citable Docs (3 years)

2.96

Cites/Doc (2 years)

103.1

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Biomolecules and Therapeutics Q2
PPAR Research Q2
Journal of Gene Medicine Q2
Current Gene Therapy Q2
Drug Development Research Q2

Compare this journals

Aims and Scope

Best articles by citations

Retinal Angiomatous Proliferation

Mitochondrial Drug Targets in Apicomplexan Parasites

Molecular Targeting of Drug Delivery Systems to Cancer

Polypoidal Choroidal Vasculopathy: Recent Advances in Therapy

Molecular Targets for Design of Novel Inhibitors to Circumvent Aminoglycoside Resistance

Chemokines and Their Receptors in Central Nervous System Disease

Chemokines as Potential Therapeutic Targets in Atherosclerosis

Chemokines in Gastrointestinal Disorders

Discovery of Novel Vaccine Candidates and Drug Targets Against Visceral Leishmaniasis Using Proteomics and Transcriptomics

Chemokines in Rheumatic Diseases

Computational Approaches for Elucidating Protein-Protein Interactions in Cation Channel Signaling

Targeting Purine and Pyrimidine Metabolism in Human Apicomplexan Parasites

SHOW MORE ARTICLES

Perspectives On Membrane-associated Progesterone Receptors As Prospective Therapeutic Targets

Isoprenoid Biosynthesis of the Apicoplast as Drug Target

Aqueous Extracts of Selected Potentilla Species Modulate Biological Activity of Human Normal Colon Cells

Prevalence and clinical significance of visible oral lesions in patients with Fanconi Anemia at risk for head and neck cancer

Nanoparticle-Based Diagnosis and Therapy

NMDA Receptors and Learning and Memory Processes

Targeting the Arrhythmogenic Substrate in Atrial Fibrillation: Focus on Structural Remodeling

Modifying Radiation Damage

Molecular Modeling as a Tool for Drug Discovery

Endogenous Cannabinoid and Opioid Systems and their Role in Nicotine Addiction

Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review

ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis